Literature DB >> 26658380

Influenza Vaccine is Protective Against Laboratory-confirmed Influenza in Obese Children.

Michael A Smit1, Hai-Lin Wang, Edward Kim, Noel Barragan, Grace M Aldrovandi, Alvin Nelson El Amin, Laurene Mascola, Pia S Pannaraj.   

Abstract

BACKGROUND: Obesity emerged as a novel risk factor for severe disease during the 2009 H1N1 influenza pandemic. Murine studies indicate that obesity is associated with ineffective response to influenza vaccine, but few human studies exist. We aimed to determine if influenza vaccine is protective against laboratory-confirmed influenza in obese children.
METHODS: Body mass index, vaccination status, and laboratory-confirmed influenza data were analyzed from a previously conducted prospective study in which active surveillance for influenza-like illness was conducted in 8 elementary schools in Los Angeles County during the 2010-2011 influenza season. Polymerase-chain reaction (PCR) was performed on combined nose/throat swabs collected from children with influenza-like illness at presentation to the school nurse or during absenteeism.
RESULTS: Of 4260 children with height/weight data, 1191 (28.0%) were obese (body mass index ≥95th percentile). Respiratory specimens were obtained from 858 (20.1%) children. Unvaccinated obese compared with vaccinated obese children acquired 3 times more PCR-confirmed influenza (62 vs. 17 per 1000 children, P = 0.003) and missed more school days (4.6 vs. 3.2 per 100 school days, P < 0.001) during influenza season. Obese children with PCR-confirmed influenza were more likely to present with cough (86.2 vs. 72.4%, P = 0.030) and missed more school per episode (2.4 vs.1.9 days, P = 0.023) compared with nonobese children. Among vaccinated children, rates of PCR-confirmed influenza were similar in obese and nonobese children (17 vs. 20 per 1000 children, P = 0.77).
CONCLUSIONS: Obese children with PCR-confirmed influenza suffered from more cough and missed more school days than their nonobese peers. Influenza vaccination protected obese children against PCR-proven influenza illness.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26658380      PMCID: PMC4788535          DOI: 10.1097/INF.0000000000001029

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  38 in total

1.  Impaired immunogenicity of hepatitis B vaccine in obese persons.

Authors:  D J Weber; W A Rutala; G P Samsa; S E Bradshaw; S M Lemon
Journal:  N Engl J Med       Date:  1986-05-22       Impact factor: 91.245

2.  Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine.

Authors:  D J Weber; W A Rutala; G P Samsa; J E Santimaw; S M Lemon
Journal:  JAMA       Date:  1985-12-13       Impact factor: 56.272

3.  Impact of body mass index on immunogenicity of pandemic H1N1 vaccine in children and adults.

Authors:  S Todd Callahan; Mark Wolff; Heather R Hill; Kathryn M Edwards
Journal:  J Infect Dis       Date:  2014-05-01       Impact factor: 5.226

4.  Reduced tetanus antibody titers in overweight children.

Authors:  Alon Eliakim; Christina Schwindt; Christina Swindt; Frank Zaldivar; Paolo Casali; Dan M Cooper
Journal:  Autoimmunity       Date:  2006-03       Impact factor: 2.815

5.  CDC growth charts: United States.

Authors:  R J Kuczmarski; C L Ogden; L M Grummer-Strawn; K M Flegal; S S Guo; R Wei; Z Mei; L R Curtin; A F Roche; C L Johnson
Journal:  Adv Data       Date:  2000-06-08

6.  Live attenuated versus inactivated influenza vaccine in infants and young children.

Authors:  Robert B Belshe; Kathryn M Edwards; Timo Vesikari; Steven V Black; Robert E Walker; Micki Hultquist; George Kemble; Edward M Connor
Journal:  N Engl J Med       Date:  2007-02-15       Impact factor: 91.245

7.  Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.

Authors:  Douglas M Fleming; Pietro Crovari; Ulrich Wahn; Timo Klemola; Yechiel Schlesinger; Alexangros Langussis; Knut Øymar; Maria Luz Garcia; Alain Krygier; Herculano Costa; Ulrich Heininger; Jean-Louis Pregaldien; Sheau-Mei Cheng; Jonathan Skinner; Ahmad Razmpour; Melanie Saville; William C Gruber; Bruce Forrest
Journal:  Pediatr Infect Dis J       Date:  2006-10       Impact factor: 2.129

8.  Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.

Authors:  Shai Ashkenazi; Andre Vertruyen; Javier Arístegui; Susanna Esposito; David Douglas McKeith; Timo Klemola; Jiri Biolek; Joachim Kühr; Tadeusz Bujnowski; Daniel Desgrandchamps; Sheau-Mei Cheng; Jonathan Skinner; William C Gruber; Bruce D Forrest
Journal:  Pediatr Infect Dis J       Date:  2006-10       Impact factor: 2.129

9.  Selective impairment in dendritic cell function and altered antigen-specific CD8+ T-cell responses in diet-induced obese mice infected with influenza virus.

Authors:  Alexia G Smith; Patricia A Sheridan; Raymond J Tseng; John F Sheridan; Melinda A Beck
Journal:  Immunology       Date:  2008-08-27       Impact factor: 7.397

10.  Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report.

Authors:  Sarah E Barlow
Journal:  Pediatrics       Date:  2007-12       Impact factor: 7.124

View more
  6 in total

1.  Influenza in obese travellers: increased risk and complications, decreased vaccine effectiveness.

Authors:  Rebekah Honce; Stacey Schultz-Cherry
Journal:  J Travel Med       Date:  2019-05-10       Impact factor: 8.490

2.  Differential gene expression elicited by children in response to the 2015-16 live attenuated versus inactivated influenza vaccine.

Authors:  Kelly Stefano Cole; Judith M Martin; William T Horne; Chyongchiou J Lin; Mary Patricia Nowalk; John F Alcorn; Richard K Zimmerman
Journal:  Vaccine       Date:  2017-11-11       Impact factor: 3.641

Review 3.  Host Factors Impact Vaccine Efficacy: Implications for Seasonal and Universal Influenza Vaccine Programs.

Authors:  Santosh Dhakal; Sabra L Klein
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

4.  Increased risk of influenza among vaccinated adults who are obese.

Authors:  S D Neidich; W D Green; J Rebeles; E A Karlsson; S Schultz-Cherry; T L Noah; S Chakladar; M G Hudgens; S S Weir; M A Beck
Journal:  Int J Obes (Lond)       Date:  2017-06-06       Impact factor: 5.095

Review 5.  Impact of Obesity on Influenza A Virus Pathogenesis, Immune Response, and Evolution.

Authors:  Rebekah Honce; Stacey Schultz-Cherry
Journal:  Front Immunol       Date:  2019-05-10       Impact factor: 7.561

6.  Preliminary results of official influenza and acute respiratory infection surveillance in two towns of Burkina Faso, 2013-2015.

Authors:  Tani Sagna; Abdoul Kader Ilboudo; Carine Wandaogo; Assana Cissé; Moussa Sana; Dieudonné Tialla; Armel Moumouni Sanou; David J Muscatello; Zékiba Tarnagda
Journal:  BMC Infect Dis       Date:  2018-07-16       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.